nodes	percent_of_prediction	percent_of_DWPC	metapath
Emedastine—Asthenopia—Tretinoin—peripheral nervous system neoplasm	0.0654	0.0654	CcSEcCtD
Emedastine—Asthenopia—Isotretinoin—peripheral nervous system neoplasm	0.0654	0.0654	CcSEcCtD
Emedastine—Asthenopia—Alitretinoin—peripheral nervous system neoplasm	0.0495	0.0495	CcSEcCtD
Emedastine—Ocular hyperaemia—Tretinoin—peripheral nervous system neoplasm	0.0267	0.0267	CcSEcCtD
Emedastine—Ocular hyperaemia—Isotretinoin—peripheral nervous system neoplasm	0.0267	0.0267	CcSEcCtD
Emedastine—Endophthalmitis—Tretinoin—peripheral nervous system neoplasm	0.0263	0.0263	CcSEcCtD
Emedastine—Endophthalmitis—Isotretinoin—peripheral nervous system neoplasm	0.0263	0.0263	CcSEcCtD
Emedastine—Ocular hyperaemia—Alitretinoin—peripheral nervous system neoplasm	0.0203	0.0203	CcSEcCtD
Emedastine—Endophthalmitis—Alitretinoin—peripheral nervous system neoplasm	0.02	0.02	CcSEcCtD
Emedastine—Keratitis—Isotretinoin—peripheral nervous system neoplasm	0.0193	0.0193	CcSEcCtD
Emedastine—Keratitis—Tretinoin—peripheral nervous system neoplasm	0.0193	0.0193	CcSEcCtD
Emedastine—Stinging—Tretinoin—peripheral nervous system neoplasm	0.0155	0.0155	CcSEcCtD
Emedastine—Stinging—Isotretinoin—peripheral nervous system neoplasm	0.0155	0.0155	CcSEcCtD
Emedastine—Eye irritation—Isotretinoin—peripheral nervous system neoplasm	0.0147	0.0147	CcSEcCtD
Emedastine—Eye irritation—Tretinoin—peripheral nervous system neoplasm	0.0147	0.0147	CcSEcCtD
Emedastine—Keratitis—Alitretinoin—peripheral nervous system neoplasm	0.0146	0.0146	CcSEcCtD
Emedastine—Lacrimation increased—Isotretinoin—peripheral nervous system neoplasm	0.0136	0.0136	CcSEcCtD
Emedastine—Lacrimation increased—Tretinoin—peripheral nervous system neoplasm	0.0136	0.0136	CcSEcCtD
Emedastine—Stinging—Alitretinoin—peripheral nervous system neoplasm	0.0117	0.0117	CcSEcCtD
Emedastine—Dry eye—Tretinoin—peripheral nervous system neoplasm	0.0116	0.0116	CcSEcCtD
Emedastine—Dry eye—Isotretinoin—peripheral nervous system neoplasm	0.0116	0.0116	CcSEcCtD
Emedastine—Eye irritation—Alitretinoin—peripheral nervous system neoplasm	0.0111	0.0111	CcSEcCtD
Emedastine—Lacrimation increased—Alitretinoin—peripheral nervous system neoplasm	0.0103	0.0103	CcSEcCtD
Emedastine—Dry eye—Alitretinoin—peripheral nervous system neoplasm	0.00877	0.00877	CcSEcCtD
Emedastine—Lacrimation—Epirubicin—peripheral nervous system neoplasm	0.00707	0.00707	CcSEcCtD
Emedastine—Sinusitis—Tretinoin—peripheral nervous system neoplasm	0.00658	0.00658	CcSEcCtD
Emedastine—Sinusitis—Isotretinoin—peripheral nervous system neoplasm	0.00658	0.00658	CcSEcCtD
Emedastine—Lacrimation—Doxorubicin—peripheral nervous system neoplasm	0.00654	0.00654	CcSEcCtD
Emedastine—Keratitis—Epirubicin—peripheral nervous system neoplasm	0.00641	0.00641	CcSEcCtD
Emedastine—Rhinitis—Topotecan—peripheral nervous system neoplasm	0.00636	0.00636	CcSEcCtD
Emedastine—Keratitis—Doxorubicin—peripheral nervous system neoplasm	0.00593	0.00593	CcSEcCtD
Emedastine—Eye disorder—Isotretinoin—peripheral nervous system neoplasm	0.00588	0.00588	CcSEcCtD
Emedastine—Eye disorder—Tretinoin—peripheral nervous system neoplasm	0.00588	0.00588	CcSEcCtD
Emedastine—Mental disorder—Tretinoin—peripheral nervous system neoplasm	0.00551	0.00551	CcSEcCtD
Emedastine—Mental disorder—Isotretinoin—peripheral nervous system neoplasm	0.00551	0.00551	CcSEcCtD
Emedastine—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00516	0.00516	CcSEcCtD
Emedastine—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00516	0.00516	CcSEcCtD
Emedastine—Stinging—Epirubicin—peripheral nervous system neoplasm	0.00513	0.00513	CcSEcCtD
Emedastine—Sinusitis—Alitretinoin—peripheral nervous system neoplasm	0.00499	0.00499	CcSEcCtD
Emedastine—Stinging—Doxorubicin—peripheral nervous system neoplasm	0.00475	0.00475	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.00467	0.00467	CcSEcCtD
Emedastine—Discomfort—Topotecan—peripheral nervous system neoplasm	0.00465	0.00465	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.00463	0.00463	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.00463	0.00463	CcSEcCtD
Emedastine—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.00461	0.00461	CcSEcCtD
Emedastine—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00461	0.00461	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.00457	0.00457	CcSEcCtD
Emedastine—Lacrimation increased—Epirubicin—peripheral nervous system neoplasm	0.00451	0.00451	CcSEcCtD
Emedastine—Eye disorder—Alitretinoin—peripheral nervous system neoplasm	0.00446	0.00446	CcSEcCtD
Emedastine—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00442	0.00442	CcSEcCtD
Emedastine—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00439	0.00439	CcSEcCtD
Emedastine—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00439	0.00439	CcSEcCtD
Emedastine—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.00438	0.00438	CcSEcCtD
Emedastine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00436	0.00436	CcSEcCtD
Emedastine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00436	0.00436	CcSEcCtD
Emedastine—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.00434	0.00434	CcSEcCtD
Emedastine—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.00434	0.00434	CcSEcCtD
Emedastine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00431	0.00431	CcSEcCtD
Emedastine—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00429	0.00429	CcSEcCtD
Emedastine—Cardiac disorder—Vincristine—peripheral nervous system neoplasm	0.00427	0.00427	CcSEcCtD
Emedastine—Mental disorder—Alitretinoin—peripheral nervous system neoplasm	0.00418	0.00418	CcSEcCtD
Emedastine—Lacrimation increased—Doxorubicin—peripheral nervous system neoplasm	0.00417	0.00417	CcSEcCtD
Emedastine—Abnormal dreams—Epirubicin—peripheral nervous system neoplasm	0.00411	0.00411	CcSEcCtD
Emedastine—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.00403	0.00403	CcSEcCtD
Emedastine—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00391	0.00391	CcSEcCtD
Emedastine—Pain—Topotecan—peripheral nervous system neoplasm	0.00385	0.00385	CcSEcCtD
Emedastine—Dry eye—Epirubicin—peripheral nervous system neoplasm	0.00384	0.00384	CcSEcCtD
Emedastine—Pain—Tretinoin—peripheral nervous system neoplasm	0.00382	0.00382	CcSEcCtD
Emedastine—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00382	0.00382	CcSEcCtD
Emedastine—Abnormal dreams—Doxorubicin—peripheral nervous system neoplasm	0.0038	0.0038	CcSEcCtD
Emedastine—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.0038	0.0038	CcSEcCtD
Emedastine—Pain—Melphalan—peripheral nervous system neoplasm	0.00377	0.00377	CcSEcCtD
Emedastine—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.00377	0.00377	CcSEcCtD
Emedastine—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00377	0.00377	CcSEcCtD
Emedastine—Dry eye—Doxorubicin—peripheral nervous system neoplasm	0.00355	0.00355	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.00351	0.00351	CcSEcCtD
Emedastine—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00349	0.00349	CcSEcCtD
Emedastine—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.00348	0.00348	CcSEcCtD
Emedastine—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.00346	0.00346	CcSEcCtD
Emedastine—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.00334	0.00334	CcSEcCtD
Emedastine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00333	0.00333	CcSEcCtD
Emedastine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00332	0.00332	CcSEcCtD
Emedastine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00331	0.00331	CcSEcCtD
Emedastine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00329	0.00329	CcSEcCtD
Emedastine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00323	0.00323	CcSEcCtD
Emedastine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00321	0.00321	CcSEcCtD
Emedastine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00321	0.00321	CcSEcCtD
Emedastine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.0032	0.0032	CcSEcCtD
Emedastine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00319	0.00319	CcSEcCtD
Emedastine—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Emedastine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Emedastine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00316	0.00316	CcSEcCtD
Emedastine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00316	0.00316	CcSEcCtD
Emedastine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00313	0.00313	CcSEcCtD
Emedastine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00312	0.00312	CcSEcCtD
Emedastine—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.00309	0.00309	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00299	0.00299	CcSEcCtD
Emedastine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00298	0.00298	CcSEcCtD
Emedastine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.0029	0.0029	CcSEcCtD
Emedastine—Rash—Topotecan—peripheral nervous system neoplasm	0.00284	0.00284	CcSEcCtD
Emedastine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00284	0.00284	CcSEcCtD
Emedastine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00283	0.00283	CcSEcCtD
Emedastine—Headache—Topotecan—peripheral nervous system neoplasm	0.00282	0.00282	CcSEcCtD
Emedastine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00282	0.00282	CcSEcCtD
Emedastine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00282	0.00282	CcSEcCtD
Emedastine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00282	0.00282	CcSEcCtD
Emedastine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00282	0.00282	CcSEcCtD
Emedastine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00282	0.00282	CcSEcCtD
Emedastine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.0028	0.0028	CcSEcCtD
Emedastine—Headache—Tretinoin—peripheral nervous system neoplasm	0.0028	0.0028	CcSEcCtD
Emedastine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.0028	0.0028	CcSEcCtD
Emedastine—Pain—Vincristine—peripheral nervous system neoplasm	0.00279	0.00279	CcSEcCtD
Emedastine—Rash—Melphalan—peripheral nervous system neoplasm	0.00278	0.00278	CcSEcCtD
Emedastine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00278	0.00278	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00274	0.00274	CcSEcCtD
Emedastine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Emedastine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Emedastine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00258	0.00258	CcSEcCtD
Emedastine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00257	0.00257	CcSEcCtD
Emedastine—Pain—Cisplatin—peripheral nervous system neoplasm	0.00247	0.00247	CcSEcCtD
Emedastine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00243	0.00243	CcSEcCtD
Emedastine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.0024	0.0024	CcSEcCtD
Emedastine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00234	0.00234	CcSEcCtD
Emedastine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Emedastine—Pain—Etoposide—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Emedastine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Emedastine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00214	0.00214	CcSEcCtD
Emedastine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00213	0.00213	CcSEcCtD
Emedastine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Emedastine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Emedastine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Emedastine—Rash—Vincristine—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Emedastine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Emedastine—Headache—Vincristine—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Emedastine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Emedastine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Emedastine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.00194	0.00194	CcSEcCtD
Emedastine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00194	0.00194	CcSEcCtD
Emedastine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Emedastine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00187	0.00187	CcSEcCtD
Emedastine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.00183	0.00183	CcSEcCtD
Emedastine—Rash—Cisplatin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Emedastine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00182	0.00182	CcSEcCtD
Emedastine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Emedastine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00179	0.00179	CcSEcCtD
Emedastine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00178	0.00178	CcSEcCtD
Emedastine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Emedastine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.00169	0.00169	CcSEcCtD
Emedastine—Rash—Etoposide—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Emedastine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Emedastine—Headache—Etoposide—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Emedastine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Emedastine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00154	0.00154	CcSEcCtD
Emedastine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Emedastine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Emedastine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00145	0.00145	CcSEcCtD
Emedastine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Emedastine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00141	0.00141	CcSEcCtD
Emedastine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00135	0.00135	CcSEcCtD
Emedastine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00134	0.00134	CcSEcCtD
Emedastine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Emedastine—Pain—Epirubicin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Emedastine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Emedastine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00106	CcSEcCtD
Emedastine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Emedastine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000984	0.000984	CcSEcCtD
Emedastine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000971	0.000971	CcSEcCtD
Emedastine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000935	0.000935	CcSEcCtD
Emedastine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000934	0.000934	CcSEcCtD
Emedastine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000929	0.000929	CcSEcCtD
Emedastine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000865	0.000865	CcSEcCtD
Emedastine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000864	0.000864	CcSEcCtD
Emedastine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00086	0.00086	CcSEcCtD
